ThomasRKlumppMD
Oncology • Philadelphia, PABreast Cancer, Hematologic Oncology
Professor of Medicine, Temple University
Dr. Klumpp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Summary
- Dr. Thomas Klumpp is a hematologist-oncologist in Philadelphia, PA and is Professor of Medical Oncology with Thomas Jefferson University Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania, completed an internal medicine internship and residency at Dartmouth, a hematology-oncology fellowship and Massachusetts General Hospital, and a Bone Marrow Transplant Fellowship at Dana Farber. He has been an academic hematologist-oncologist in Philadelphia for 35 years. He specializes in hematologic malignancies, bone marrow transplantation, transfusion medicine, biostatistics, and bioinformatics.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1982 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1982
Certifications & Licensure
PA State Medical License 1990 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors Start of enrollment: 1990 Nov 01
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer Start of enrollment: 1991 Nov 01
- Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1992 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact...Chetan Jeurkar, Benjamin Leiby, Shaik Rashid, Usama Gergis, Dolores Grossso
European Journal of Haematology. 2024-09-01 - A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia.Neil Palmisiano, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi
Cancers. 2023-10-25 - 1 citationsCell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safet...Vincent T Ho, Thomas R Klumpp, Wayne H Liang, Matt Prestegaard, Mitchell Horwitz
Transplantation and Cellular Therapy. 2023-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
